Published on
CHOP's Preserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE) study was recently awarded funding from the Patient-Centered Outcomes Research Institute (PCORI). PRESERVE is a three-year, multi-institutional clinical trial evaluating blood pressure management and urine protein monitoring strategies to preserve kidney function in pediatric chronic kidney disease (CKD) patients.
Published on
Let’s say you would like to be Chief Scientific Officer and Executive Vice President at Children’s Hospital of Philadelphia. Here are just a few things you will need: a keen intellect, a sterling CV distinguished by the highest levels of clinical and research achievement, a vision for how CHOP can lead the next great advances in pediatric science, and stamina. Lots of it.
Published on
Our three new fellows reveal what makes Philly such a great place to live and work.
Published on
Enjoy this kidney-friendly recipe for chocolate, banana and peanut butter bites.
Published on
CHOP and Penn collaborate to establish a unique center that provides continuity of care for children with glomerular disease.
Published on
Following an extensive national search, Children’s Hospital of Philadelphia (CHOP) has appointed Susan L. Furth, MD, PhD as Chief Scientific Officer. In her new position, effective June 1, 2021, Dr. Furth will oversee the CHOP Research Institute.
Published on
Children’s Hospital of Philadelphia is pleased to announce that Susan Furth, MD, PhD, Chief of the Division of Nephrology, has received The Society for Pediatric Research (SPR) annual Maureen Andrew Mentor Award, which recognizes pediatricians with outstanding records of mentor leadership. The award was presented to Dr. Furth on May 4, 2021 during the SPR Plenary Session at the Pediatric Academic Societies 2021 Virtual Meeting.
Published on
The study is one of many efforts by our Division of Nephrology to help develop evidence pertaining to novel treatment options for children with chronic kidney disease.
Published on
Taken together, the Reaching Equity for Adults and CHildren (REACH) in Transplant study aims to identify objective approaches to reduce disparities in access to transplant across race/ethnicity, with particular attention to improve systems for transplant referral timing, living donor candidate evaluation and living donor follow-up.
Published on
The study’s results are expected to increase understanding of the mechanisms of bladder injury after stem cell transplant, and also hopefully improve care for other high-risk patients.